Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06540391
Title A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients (MELODY-1)
Acronym MELODY-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Microbiotica Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | GBR | FRA | ESP


No variant requirements are available.